Foundation Preparation Pallas-reactor (PALLAS) is responsible for obtaining a licensable design, obtaining private investors and constructing and operating the PALLAS-reactor.
PALLAS will help tens of thousands of patients every day by providing medical isotopes. These radioactive particles in nuclear medicine are crucial elements in order to diagnose or treat illnesses such as cardiovascular disease and cancer. PALLAS will also be an important player in (medical) nuclear technological research.
Design and construction
The design and construction is aimed at all activities that relate to the specifications, functional requirements, tender of the design, construction, and operation of the PALLAS-reactor.
To enable construction of the new reactor, various government agencies must make decisions and grant the required permits. The current zoning plan must therefore be revised. To this end, the Design & Licensing team had to submit a legally mandated Environmental Impact Assessment (EIA) for revising the zoning plan to the municipality of Schagen. This was done at the end of 2017 and the municipality of Schagen approved the zoning plan in 2019.
Within a few years, PALLAS will request a Nuclear Energy Act (NEA) permit from the Dutch Authority for Nuclear Safety and Radiation Protection (ANVS) for which a more detailed EIA is required. In addition, the NEA permit requires a comprehensive safety report. Other relevant laws for PALLAS are the Water Act for all direct discharging of cooling water, the Environmental Permitting (General Provisions) Act for location-bound activities, including construction, installation and use, and the Nature Conservancy Act for protecting nature areas.
Solid business case
PALLAS is working on establishing and maintaining a solidly substantiated and economically viable business case. Substantiation of the financial feasibility of building the PALLAS-reactor is centre stage in this respect. The goal of the business case is to successfully attract private financing for the construction, commissioning and operation of the nuclear reactor. The business case also takes the decommissioning into account.
PALLAS has the task of obtaining private financing for the following PALLAS phases: the construction, the commissioning, the operation and the decommissioning of the PALLAS-reactor. However, private funding based on conditions acceptable to the government is not (yet) feasible at this time according to the government. In her letter to the House of Representatives dated December 9, 2020, Minister Van Ark for Medical Care and Sport reported that the Cabinet considers it important to take a decision soon on how the security of supply of medical isotopes can be guaranteed for the future. This can be done, on the one hand, by gaining a good understanding of the costs, revenues and associated risks of the public variant for PALLAS and, on the other hand, by gaining a good understanding of the alternatives. In the spring of 2021, the Minister will inform the House of Representatives about this.